Mirador Capital Partners LP Has $1.59 Million Stock Holdings in Cardinal Health, Inc. (NYSE:CAH)

Mirador Capital Partners LP boosted its position in Cardinal Health, Inc. (NYSE:CAH) by 3.6% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 13,429 shares of the company’s stock after buying an additional 466 shares during the quarter. Mirador Capital Partners LP’s holdings in Cardinal Health were worth $1,588,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also bought and sold shares of the company. State Street Corp raised its position in Cardinal Health by 4.6% in the 3rd quarter. State Street Corp now owns 14,177,641 shares of the company’s stock valued at $1,566,913,000 after buying an additional 627,253 shares during the last quarter. Geode Capital Management LLC raised its position in Cardinal Health by 0.7% in the 3rd quarter. Geode Capital Management LLC now owns 5,749,859 shares of the company’s stock valued at $633,298,000 after buying an additional 42,082 shares during the last quarter. Pacer Advisors Inc. raised its position in Cardinal Health by 4.7% in the 3rd quarter. Pacer Advisors Inc. now owns 4,290,650 shares of the company’s stock valued at $474,203,000 after buying an additional 191,568 shares during the last quarter. ProShare Advisors LLC increased its position in shares of Cardinal Health by 5.1% during the 2nd quarter. ProShare Advisors LLC now owns 1,759,299 shares of the company’s stock worth $172,974,000 after purchasing an additional 85,247 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. increased its position in shares of Cardinal Health by 2.3% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,474,625 shares of the company’s stock worth $162,976,000 after purchasing an additional 33,388 shares during the last quarter. Institutional investors and hedge funds own 87.17% of the company’s stock.

Wall Street Analyst Weigh In

CAH has been the subject of several recent research reports. Barclays boosted their price target on Cardinal Health from $117.00 to $133.00 and gave the company an “overweight” rating in a research note on Monday, November 4th. Bank of America upgraded Cardinal Health from a “neutral” rating to a “buy” rating and boosted their price target for the company from $132.00 to $145.00 in a research note on Monday, January 6th. Citigroup boosted their price target on Cardinal Health from $120.00 to $129.00 and gave the company a “neutral” rating in a research note on Friday, January 10th. StockNews.com downgraded Cardinal Health from a “strong-buy” rating to a “buy” rating in a research note on Sunday, November 3rd. Finally, Wells Fargo & Company upgraded Cardinal Health from an “underweight” rating to an “equal weight” rating and upped their target price for the company from $101.00 to $127.00 in a research report on Friday, December 13th. Four investment analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $133.29.

Cardinal Health Stock Down 0.0 %

Shares of CAH opened at $124.67 on Thursday. Cardinal Health, Inc. has a 12-month low of $93.17 and a 12-month high of $126.23. The business has a 50-day simple moving average of $120.46 and a two-hundred day simple moving average of $111.50. The stock has a market cap of $30.17 billion, a PE ratio of 24.25, a PEG ratio of 1.48 and a beta of 0.63.

Cardinal Health (NYSE:CAH) last issued its earnings results on Friday, November 1st. The company reported $1.88 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.62 by $0.26. Cardinal Health had a negative return on equity of 56.56% and a net margin of 0.56%. The business had revenue of $52.28 billion during the quarter, compared to analysts’ expectations of $50.90 billion. During the same quarter in the prior year, the firm earned $1.73 EPS. The business’s revenue for the quarter was down 4.3% compared to the same quarter last year. On average, equities research analysts expect that Cardinal Health, Inc. will post 7.82 EPS for the current year.

Cardinal Health Cuts Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, January 15th. Shareholders of record on Thursday, January 2nd were issued a $0.5056 dividend. The ex-dividend date of this dividend was Thursday, January 2nd. This represents a $2.02 dividend on an annualized basis and a yield of 1.62%. Cardinal Health’s payout ratio is presently 39.30%.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.